Vimizim Coupon & Prices

Your monthly Vimizim cost savings if eligible

If you are eligible for the Vimizim patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Vimizim through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.

Am I eligible for the Vimizim patient assistance program?

You could receive your Vimizim without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for Vimizim patient assistance?

We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Vimizim.

NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Vimizim patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Vimizim medication refills on your behalf for up to 1 year once you are enrolled in the program.

Is NiceRx a Vimizim coupons provider?

At NiceRx, we help eligible individuals access the Vimizim patient assistance program. This means that we are not a Vimizim coupon, a Vimizim discount card, or a Vimizim copay card provider. We do not offer any medication trial offers or free Vimizim samples.

Can NiceRx help me get Vimizim if I have insurance?

We may be able to help you if you have insurance, including if your insurance company will not pay for your Vimizim medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.

How much does Vimizim cost without insurance?

Vimizim costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Vimizim intravenous solution (1 mg/mL) will typically cost around $1,330 for 5 milliliters. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.

How much does Vimizim cost with insurance?

The copay of Vimizim will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.

What is Vimizim?

Vimizim is an FDA (U.S. Food and Drug Administration) approved medication manufactured by BioMarin Pharmaceutical Inc. Vimizim is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme replacement therapy indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). The underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) is a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase (GALNS). Vimizim works at a cellular level to help with deficient enzyme activity.

Spinal cord damage or cervical cord compression may occur due to the natural MPS IVA disease process. Signs of spinal cord injury include back pain, numbness and paralysis, and loss of bladder and bowel control.

Risk of anaphylaxis – See the full prescribing information for the complete boxed warning. Life-threatening anaphylactic reactions have occurred in some patients during Vimizim infusions. Anaphylaxis symptoms include cough, erythema, throat tightness, hives, flushing, cyanosis, hypotension, rash, dyspnea, shortness of breath, chest discomfort, and gastrointestinal symptoms such as nausea, abdominal pain, retching, and vomiting in conjunction with urticaria. Inform patients of the signs and symptoms of anaphylaxis and have them seek immediate medical care should symptoms occur. Patients with acute respiratory illness may be at risk of serious acute exacerbation of their respiratory compromise due to hypersensitivity reactions and require additional monitoring.

What doses of Vimizim are available?

Vimizim is available in injection form, in the following doses: 5 mg/5 mL (1 mg/mL) in single-use vials.

Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.

Vimizim active ingredients

Vimizim contains elosulfase alfa as the active ingredient.

Vimizim side effects

The most common adverse reactions of Vimizim in clinical trials compared to placebo include:

• Pyrexia
• Vomiting
• Headache, nausea
• Abdominal pain
• Chills, and fatigue

In rare instances, Vimizim can cause more serious side effects. These can include:

• Anaphylaxis – this can occur during any Vimizim infusion, as early as 30 minutes from the start and up to 3 hours after infusion, and as late into treatment as the 47th infusion
• Life-threatening hypersensitivity reactions – if anaphylaxis or severe hypersensitivity reactions occur, immediately stop the infusion and initiate appropriate medical treatment. Pre-treatment with antihistamines with or without antipyretics is recommended prior to the start of infusion
• Risk of acute respiratory complications – patients with acute febrile or respiratory illness may be at higher risk of life-threatening complications from hypersensitivity reactions

Your doctor will assess the benefits of using Vimizim against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Vimizim to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Vimizim drug interactions

There is currently no data for Evkeeza interactions with other medications. Tell your healthcare provider about all the medicines you take, including prescription drugs and over-the-counter medicines, vitamins, and herbal supplements.

Vimizim contraindications

You should not use Vimizim if you:

• Are allergic to the active ingredient elosulfase alfa
• Have had an allergic reaction to any of the other ingredients in Vimizim

Talk to your doctor before using Vimizim if you:

• Are taking any of the medications that could interact with Vimizim
• Are pregnant or are planning to become pregnant
• Are breastfeeding or are planning to breastfeed
• Have had any breathing problems
• Have sleep apnea, and you use a continuous positive airway pressure (CPAP) machine

Vimizim generic

Vimizim is the trademark brand name for elosulfase alfa manufactured by BioMarin Pharmaceutical Inc. A generic version of elosulfase alfa is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vimizim savings through NiceRx.